B
ZBH icon

Baird’s Zimmer Biomet ZBH Stock Holding History

Baird’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.35M Sell
11,840
-99
-0.8% -$11.3K 0.01% 665
2014
Q4 		$1.31M Buy
11,939
+9,279
+349% +$978K 0.01% 665
2014
Q3 		$260K Sell
2,660
-332
-11% -$32.7K ﹤0.01% 1009
2014
Q2 		$302K Sell
2,992
-406
-12% -$39.6K ﹤0.01% 980
2014
Q1 		$312K Sell
3,398
-196
-5% -$18.1K ﹤0.01% 974
2013
Q4 		$325K Sell
3,594
-580
-14% -$50.2K 0.01% 943
2013
Q3 		$333K Buy
4,174
+508
+14% +$40K 0.01% 912
2013
Q2 		$267K Buy
+3,666
New +$274K 0.01% 933

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baird's ZBH Position: Q1 2015 in Review

Baird reduced its Zimmer Biomet (ZBH) stake by 0.83% in Q1 2015, selling an estimated $11.3K and leaving 11,840 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #665.

Baird first reported a position in ZBH in Q2 2013 and has held it in 8 quarters since. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • Baird held 11,840 shares of Zimmer Biomet worth $1.35M as of Q1 2015.
  • Baird sold 99 Zimmer Biomet shares in Q1 2015, an estimated $11.3K.
  • Zimmer Biomet made up 0.01% of Baird's portfolio in Q1 2015, its #665 holding.
  • Baird first reported a position in Zimmer Biomet in Q2 2013 and has held it in 8 quarters since.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.